SB
Sujata Bhashker Dabral
About Sujata Bhashker Dabral
Data last updated:
Sujata Bhashker Dabral is a Director at Acies Pharmaceutical Private Limited (since 2019), Director at Alexon Healthcare Private Limited (since 2023) and Designated Partner at Acies Lifesciences Llp (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹39.73 Cr; the largest is Acies Pharmaceutical Private Limited at ₹37.03 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Acies Pharmaceutical Private Limited U74999UR2019PTC009735 | Director | 19 Apr 2019 | 2019 | ₹37.03 Cr (FY 2025) | Active |
 Alexon Healthcare Private Limited U24290UP2022PTC171776 | Director | 28 Oct 2023 | 2022 | ₹2.70 Cr (FY 2024) | Active |
| Acies Lifesciences Llp ACP-1019 | Designated Partner | 13 Jun 2025 | 2025 | Active |
Board colleagues of Sujata Bhashker Dabral
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhasker Dabral | 08426742 | Acies Pharmaceutical Private Limited , Alexon Healthcare Private Limited | Director |
| Ishti Singhal Gupta | 08353673 | Acies Lifesciences Llp | Designated Partner |
| Rahul Singhal | 10885931 | Acies Lifesciences Llp | Designated Partner |
| Vipul Mittal | 02483560 | Acies Lifesciences Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sujata Bhashker Dabral
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sujata Bhashker Dabral
Sujata Bhashker Dabral currently holds 3 directorships: Acies Pharmaceutical Private Limited (Director, since 19 Apr 2019, revenue ₹37.03 Cr (FY 2025)); Alexon Healthcare Private Limited (Director, since 28 Oct 2023, revenue ₹2.70 Cr (FY 2024)); Acies Lifesciences Llp (Designated Partner, since 13 Jun 2025).
Sujata Bhashker Dabral was first appointed on 19 Apr 2019 as Director at Acies Pharmaceutical Private Limited. The most recent appointment on record is 13 Jun 2025 at Acies Lifesciences Llp.
The 2 current companies of Sujata Bhashker Dabral that report revenue have a combined latest revenue of ₹39.73 Cr: Acies Pharmaceutical Private Limited ₹37.03 Cr (FY 2025); Alexon Healthcare Private Limited ₹2.70 Cr (FY 2024).
The current boards of Sujata Bhashker Dabral's companies include Bhasker Dabral (Acies Pharmaceutical Private Limited), Ishti Singhal Gupta (Acies Lifesciences Llp), Rahul Singhal (Acies Lifesciences Llp), Vipul Mittal (Acies Lifesciences Llp).